Prestige Consumer Healthcare Inc (PBH)
ROE
Obliczenia
|
2023 (31 mar 2023) |
2022 (31 mar 2022) |
2021 (31 mar 2021) |
2020 (31 mar 2020) |
2019 (31 mar 2019) |
||
|---|---|---|---|---|---|---|
| Zysk netto | w tys. USD | -82 306 | 205 381 | 164 682 | 142 281 | -35 800 |
| Kapitał własny | w tys. USD | 1 447 080 | 1 577 610 | 1 358 300 | 1 170 970 | 1 095 830 |
| ROE | -5,69% | 13,02% | 12,12% | 12,15% | -3,27% |
2023 obliczenia
ROE = Zysk netto ÷ Kapitał własny
= $-82 306K ÷ $1 447 080K
= -5,69%
Analiza porównawcza
2023
Nazwa spółki
Symbol
ROE
Prestige Consumer Healthcare Inc
PBH
-5,69%
Amphastar Pharmaceuticals Inc
AMPH
21,51%
Catalyst Pharmaceuticals Inc
CPRX
18,41%
Corcept Therapeutics Inc
CORT
20,95%
Cytokinetics Inc
CYTK
—
Harmony Biosciences Holdings Inc
HRMY
27,59%
Ironwood Pharmaceuticals Inc
IRWD
—
Pacira BioSciences Inc
PCRX
4,82%
Schrodinger Inc
SDGR
7,42%
Supernus Pharmaceuticals Inc
SUPN
0,14%
Xencor Inc
XNCR
-18,85%